Literature DB >> 7295349

Actions of 3-deazaguanine and 3-deazaguanosine on variant lines of Chinese hamster ovary cells.

P P Saunders, L Y Chao, T L Loo, R K Robins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7295349     DOI: 10.1016/0006-2952(81)90118-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  7 in total

1.  Studies on the mechanism of 3-deazaguanine cytotoxicity in L1210-sensitive and -resistant cell lines.

Authors:  G Singh; M K Luna; B Ardalan
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  Dezaguanine mesylate: a new antipurine antimetabolite.

Authors:  W R Leopold; D W Fry; T J Boritzki; J A Besserer; I C Pattison; R C Jackson
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

3.  Studies on the mechanism of cytotoxicity of 3-deazaguanosine in human cancer cells.

Authors:  T Page; S J Jacobsen; R M Smejkal; J Scheele; W L Nyhan; J H Mangum; R K Robins
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

4.  Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.

Authors:  D L Lucas; H K Webster; D G Wright
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

5.  A new synthesis of certain 7-(beta-D-ribofuranosyl) and 7-(2-deoxy-beta-D-ribofuranosyl) derivatives of 3-deazaguanine via the sodium salt glycosylation procedure.

Authors:  P K Gupta; R K Robins; G R Revankar
Journal:  Nucleic Acids Res       Date:  1985-07-25       Impact factor: 16.971

6.  Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin.

Authors:  J J Kirsi; P A McKernan; N J Burns; J A North; B K Murray; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

7.  Clinical pharmacokinetics of 3-deazaguanine.

Authors:  L Pendyala; P J Creaven; L R Whitfield
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.